Characterization of Human Mesenchymal Stem Cells from Ewing Sarcoma Patients. Pathogenetic Implications

• Ana Teresa Amaral,

  Affiliations Molecular Pathology Program, Institute of Biomedical Research of Salamanca-Centro de Investigación del Cáncer, Centro de Investigación del Cáncer (IBSAL-CIC), Salamanca, Spain, Instituto de Biomedicina de Sevilla (IBiS), CSIC-Universidad de Sevilla, Department of Pathology and Biobank, Hospital Universitario Virgen del Rocío, Seville, Spain

  ⨯
• Maria Cristina Manara,

  Affiliation CRS Sviluppo di Terapie Biomolecolari, Oncologia Sperimentale, Istituto Ortopedico Rizzoli (IOR), Bologna, Italy

  ⨯
• Dagmar Berghuis,

  Affiliation Department of Pediatrics and Biobank, Leiden University Medical Center (LUMC), Leiden, The Netherlands

  ⨯
• José Luis Ordóñez,

  Affiliation Molecular Pathology Program, Institute of Biomedical Research of Salamanca-Centro de Investigación del Cáncer, Centro de Investigación del Cáncer (IBSAL-CIC), Salamanca, Spain

  ⨯
• Michele Biscuola,

  Affiliation Instituto de Biomedicina de Sevilla (IBiS), CSIC-Universidad de Sevilla, Department of Pathology and Biobank, Hospital Universitario Virgen del Rocío, Seville, Spain

  ⨯
• Maria Angeles Lopez-García,

  Affiliation Instituto de Biomedicina de Sevilla (IBiS), CSIC-Universidad de Sevilla, Department of Pathology and Biobank, Hospital Universitario Virgen del Rocío, Seville, Spain

  ⨯
• Daniel Osuna,

  Affiliation Molecular Pathology Program, Institute of Biomedical Research of Salamanca-Centro de Investigación del Cáncer, Centro de Investigación del Cáncer (IBSAL-CIC), Salamanca, Spain

  ⨯
• Enrico Lucarelli,

  Affiliation Osteoarticolar Regeneration Laboratory, Istituto Ortopedico Rizzoli (IOR), Bologna, Italy

  ⨯
• Francesco Alviano,

  Affiliation Dipartimento di Istologia, Embriologia e Biologia, Istituto Ortopedico Rizzoli (IOR), Bologna, Italy

  ⨯
• Arjan Lankester,

  Affiliation Department of Pediatrics and Biobank, Leiden University Medical Center (LUMC), Leiden, The Netherlands

  ⨯
• Katia Scotlandi,

  Affiliation CRS Sviluppo di Terapie Biomolecolari, Oncologia Sperimentale, Istituto Ortopedico Rizzoli (IOR), Bologna, Italy

  ⨯
• Enrique de Álava

  * E-mail: edealava@usal.es

  Affiliations Molecular Pathology Program, Institute of Biomedical Research of Salamanca-Centro de Investigación del Cáncer, Centro de Investigación del Cáncer (IBSAL-CIC), Salamanca, Spain, Instituto de Biomedicina de Sevilla (IBiS), CSIC-Universidad de Sevilla, Department of Pathology and Biobank, Hospital Universitario Virgen del Rocío, Seville, Spain

  ⨯